Mumps antibody in the Thai population 17 years after the universal measles mumps rubella vaccination program

Introduction: mumps vaccination implementation in the form of MMR – measles, mumps, and rubella) in Thailand for first-grade school students since 1997 and for infants 9–12 months of age since 2010 resulted in a dramatic decline in the incidence of and deaths from mumps. However, there has been a re...

Full description

Saved in:
Bibliographic Details
Main Authors: Varisara Ngaovithunvong, Nasamon Wanlapakorn, Lita Tesapirat, Narrissara Suratannon, Yong Poovorawan
Format: Article
Language:English
Published: The Journal of Infection in Developing Countries 2016-08-01
Series:Journal of Infection in Developing Countries
Subjects:
Online Access:https://jidc.org/index.php/journal/article/view/7560
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850147979720130560
author Varisara Ngaovithunvong
Nasamon Wanlapakorn
Lita Tesapirat
Narrissara Suratannon
Yong Poovorawan
author_facet Varisara Ngaovithunvong
Nasamon Wanlapakorn
Lita Tesapirat
Narrissara Suratannon
Yong Poovorawan
author_sort Varisara Ngaovithunvong
collection DOAJ
description Introduction: mumps vaccination implementation in the form of MMR – measles, mumps, and rubella) in Thailand for first-grade school students since 1997 and for infants 9–12 months of age since 2010 resulted in a dramatic decline in the incidence of and deaths from mumps. However, there has been a resurgence of mumps outbreaks in Thailand, even in vaccinated populations. Methodology: We aimed to determine the current seroprevalence of IgG antibodies to mumps in those 0–60 years of age from four different geographic areas of Thailand, and compare the results with our previous serosurvey in 2004. Results: Seropositivity rates in children 0–7 years of age increased significantly from 45.8% in 2004 to 72.3% in 2014 after the launch of the MMR vaccine for infants. In the 8–14-year age group who had received one dose of mumps vaccination, the seropositivity rate was 66.7%. In the 15–19-year age group the seropositivity rate was the lowest, at 52.5%. Discussion: Our findings correspond well with the vaccination schedules, as the highest seropositivity rate was found in children between 0 and 7 years of age. For those older than 7, there was a decline in seropositivity rate despite good vaccine coverage and reached its lowest in the 15–19-year age group. This suggested that certain population groups might be incompletely vaccinated, or the humoral immunity provided by vaccination gradually declined over time. Conclusions: We recommend a booster dose of MMR vaccine for Thai adolescents in order to prevent future mumps outbreaks.
format Article
id doaj-art-c4cae66f5dd04e4b9ce57755533cfa68
institution OA Journals
issn 1972-2680
language English
publishDate 2016-08-01
publisher The Journal of Infection in Developing Countries
record_format Article
series Journal of Infection in Developing Countries
spelling doaj-art-c4cae66f5dd04e4b9ce57755533cfa682025-08-20T02:27:23ZengThe Journal of Infection in Developing CountriesJournal of Infection in Developing Countries1972-26802016-08-01100710.3855/jidc.7560Mumps antibody in the Thai population 17 years after the universal measles mumps rubella vaccination programVarisara Ngaovithunvong0Nasamon Wanlapakorn1Lita Tesapirat2Narrissara Suratannon3Yong Poovorawan4Faculty of Medicine, Chulalongkorn University, Pathumwan, Bangkok, ThailandFaculty of Medicine, Chulalongkorn University, Pathumwan, Bangkok, ThailandFaculty of Medicine, Chulalongkorn University, Pathumwan, Bangkok, ThailandFaculty of Medicine, Chulalongkorn University, Pathumwan, Bangkok, ThailandFaculty of Medicine, Chulalongkorn University, Pathumwan, Bangkok, ThailandIntroduction: mumps vaccination implementation in the form of MMR – measles, mumps, and rubella) in Thailand for first-grade school students since 1997 and for infants 9–12 months of age since 2010 resulted in a dramatic decline in the incidence of and deaths from mumps. However, there has been a resurgence of mumps outbreaks in Thailand, even in vaccinated populations. Methodology: We aimed to determine the current seroprevalence of IgG antibodies to mumps in those 0–60 years of age from four different geographic areas of Thailand, and compare the results with our previous serosurvey in 2004. Results: Seropositivity rates in children 0–7 years of age increased significantly from 45.8% in 2004 to 72.3% in 2014 after the launch of the MMR vaccine for infants. In the 8–14-year age group who had received one dose of mumps vaccination, the seropositivity rate was 66.7%. In the 15–19-year age group the seropositivity rate was the lowest, at 52.5%. Discussion: Our findings correspond well with the vaccination schedules, as the highest seropositivity rate was found in children between 0 and 7 years of age. For those older than 7, there was a decline in seropositivity rate despite good vaccine coverage and reached its lowest in the 15–19-year age group. This suggested that certain population groups might be incompletely vaccinated, or the humoral immunity provided by vaccination gradually declined over time. Conclusions: We recommend a booster dose of MMR vaccine for Thai adolescents in order to prevent future mumps outbreaks. https://jidc.org/index.php/journal/article/view/7560mumpsseroprevalenceEPIThailand
spellingShingle Varisara Ngaovithunvong
Nasamon Wanlapakorn
Lita Tesapirat
Narrissara Suratannon
Yong Poovorawan
Mumps antibody in the Thai population 17 years after the universal measles mumps rubella vaccination program
Journal of Infection in Developing Countries
mumps
seroprevalence
EPI
Thailand
title Mumps antibody in the Thai population 17 years after the universal measles mumps rubella vaccination program
title_full Mumps antibody in the Thai population 17 years after the universal measles mumps rubella vaccination program
title_fullStr Mumps antibody in the Thai population 17 years after the universal measles mumps rubella vaccination program
title_full_unstemmed Mumps antibody in the Thai population 17 years after the universal measles mumps rubella vaccination program
title_short Mumps antibody in the Thai population 17 years after the universal measles mumps rubella vaccination program
title_sort mumps antibody in the thai population 17 years after the universal measles mumps rubella vaccination program
topic mumps
seroprevalence
EPI
Thailand
url https://jidc.org/index.php/journal/article/view/7560
work_keys_str_mv AT varisarangaovithunvong mumpsantibodyinthethaipopulation17yearsaftertheuniversalmeaslesmumpsrubellavaccinationprogram
AT nasamonwanlapakorn mumpsantibodyinthethaipopulation17yearsaftertheuniversalmeaslesmumpsrubellavaccinationprogram
AT litatesapirat mumpsantibodyinthethaipopulation17yearsaftertheuniversalmeaslesmumpsrubellavaccinationprogram
AT narrissarasuratannon mumpsantibodyinthethaipopulation17yearsaftertheuniversalmeaslesmumpsrubellavaccinationprogram
AT yongpoovorawan mumpsantibodyinthethaipopulation17yearsaftertheuniversalmeaslesmumpsrubellavaccinationprogram